Difference between revisions of "Part:BBa C0083:Experience"
Franksargent (Talk | contribs) (→User Reviews) |
Franksargent (Talk | contribs) (→User Reviews) |
||
Line 7: | Line 7: | ||
===User Reviews=== | ===User Reviews=== | ||
<!-- DON'T DELETE --><partinfo>BBa_K190019 StartReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K190019 StartReviews</partinfo> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
{|width='80%' style='border:1px solid gray' | {|width='80%' style='border:1px solid gray' |
Revision as of 15:39, 21 September 2011
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_C0083
User Reviews
UNIQ359fcdc9e7dba8b6-partinfo-00000000-QINU
•••
iGEM Dundee 2011 |
We found the sequence of this part to be correct as listed and modified it by the addition of a microcompartment targeting domain and an HA epitope tag (as BBa_K562018). This will allow better monitoring of production of the protein. Indeed, we could detect production of this fusion in E. coli using an anti-HA monoclonal antibody. We did not get the chance to test arsenic resistance in a host cell producing this part. |
UNIQ359fcdc9e7dba8b6-partinfo-00000003-QINU